Teknisk og drift
Denne siden fornyes snart!
Oslo, 16 April 2018: Photocure ASA (OSE: PHO), calls for the annual general meeting of PHO to be held at Hoffsveien 4, 1st floor, 0275 Oslo, Norway on 9 May 2018 at 17:00 hours (CET).
The notice convening the general meeting, including the agenda and the board's proposals to the matters to be dealt with, is enclosed with this notification and will be sent to all shareholders with known addresses.
Relevant documents referred to in the notice are made available on www.photocure.no.
For further information, please contact:
CFO Erik DahlTel: +47 450 55 000, Email: email@example.com
About Photocure ASA
Photocure, headquartered in Oslo Norway, is a specialty pharmaceutical company focusing on urology. Based on its unique proprietary Photocure Technology® platform, Photocure is committed to developing and commercializing highly selective and minimally invasive solutions to improve health outcomes for patients worldwide. The company is listed on the Oslo Stock Exchange (OSE: PHO). More information about Photocure is available at www.photocure.com, www.hexvix.com, www.cysview.com.
Nyheten er levert av GlobeNewswire.